Article
MRI/MRSI is best suited for patients with newly diagnosed prostate cancer who are at high risk of extracapsular extent and who are considering various forms of local therapy.
Comparable efficacy seen with single vs. multiple OnabotulinumtoxinA injection sites in OAB
Key updates from the AUA/ASRM male infertility guideline amendment
FDA grants 510(k) clearance to Ambu’s HD cystoscopy solution
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
Category I CPT code granted to irreversible electroporation for prostate lesions
TikTok content on low testosterone lacks information on future risks, study finds